ロード中...
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
BACKGROUND: Cerebrospinal fluid (CSF) amyloid-beta (Aβ) 42/40 ratio, threonine-181-phosphorylated-tau (p-tau), and total-tau (t-tau) represent core biomarkers of Alzheimer disease (AD). The recent availability of automated platforms has represented a significant achievement for reducing the pre-anal...
保存先:
| 出版年: | Alzheimers Res Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7526419/ https://ncbi.nlm.nih.gov/pubmed/32993776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-020-00689-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|